Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Helicobacter pylori-Associated Duodenal Ulcer Disease in Adults: Developing Drugs for Treatment

Helicobacter pylori-Associated Duodenal Ulcer Disease in Adults: Developing Drugs for Treatment

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

October 5, 2009

October 17, 2019

Center for Drug Evaluation and Research

6e815a93-1ade-4976-a5a1-cf1f0cfcf6d9

Related Documents

Malaria: Developing Drugs for Treatment: Draft Guidance for Industry

Guidance DocumentSeptember 23, 2025Center for Drug Evaluation and Research
View Details →

Alcoholism: Developing Drugs for Treatment

Guidance DocumentFebruary 12, 2015Center for Drug Evaluation and Research
View Details →

Dry Eye: Developing Drugs for Treatment Guidance for Industry

Guidance DocumentDecember 16, 2020Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.